These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32945412)

  • 1. Novel oral plasminogen activator inhibitor‑1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats.
    Noguchi R; Kaji K; Namisaki T; Moriya K; Kawaratani H; Kitade M; Takaya H; Aihara Y; Douhara A; Asada K; Nishimura N; Miyata T; Yoshiji H
    Mol Med Rep; 2020 Oct; 22(4):2948-2956. PubMed ID: 32945412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats.
    Kaji K; Yoshiji H; Ikenaka Y; Noguchi R; Aihara Y; Douhara A; Moriya K; Kawaratani H; Shirai Y; Yoshii J; Yanase K; Kitade M; Namisaki T; Fukui H
    J Gastroenterol; 2014 Mar; 49(3):481-91. PubMed ID: 23475323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway.
    Huang W; Li L; Tian X; Yan J; Yang X; Wang X; Liao G; Qiu G
    Mol Med Rep; 2015 Apr; 11(4):2569-77. PubMed ID: 25435153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.
    Huang WT; Vayalil PK; Miyata T; Hagood J; Liu RM
    Am J Respir Cell Mol Biol; 2012 Jan; 46(1):87-95. PubMed ID: 21852684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.
    Nishimura N; Kitade M; Noguchi R; Namisaki T; Moriya K; Takeda K; Okura Y; Aihara Y; Douhara A; Kawaratani H; Asada K; Yoshiji H
    J Gastroenterol; 2016 Dec; 51(12):1141-1149. PubMed ID: 27025708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
    Kaji K; Yoshiji H; Kitade M; Ikenaka Y; Noguchi R; Shirai Y; Aihara Y; Namisaki T; Yoshii J; Yanase K; Tsujimoto T; Kawaratani H; Fukui H
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1094-104. PubMed ID: 21372165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
    Yang Y; Kim B; Park YK; Koo SI; Lee JY
    Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of capsaicin on hepatic stellate cells and liver fibrosis.
    Yu FX; Teng YY; Zhu QD; Zhang QY; Tang YH
    Biochem Cell Biol; 2014 Oct; 92(5):406-12. PubMed ID: 25289759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11β‑hydroxysteroid dehydrogenase‑1 is associated with the activation of hepatic stellate cells in the development of hepatic fibrosis.
    Xiao W; Lu MH; Rong PF; Zhang HY; Gong J; Peng YQ; Gong HY; Liu ZG
    Mol Med Rep; 2020 Oct; 22(4):3191-3200. PubMed ID: 32945429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
    Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
    Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
    Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
    Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
    Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
    Tao YY; Wang QL; Shen L; Fu WW; Liu CH
    Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.